Edition:
United States

Vexim SA (ALVXM.PA)

ALVXM.PA on Paris Stock Exchange

10.01EUR
28 Sep 2016
Change (% chg)

-- (--)
Prev Close
€10.01
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
8,052
52-wk High
€11.10
52-wk Low
€6.99

ALVXM.PA

Chart for ALVXM.PA

About

Vexim SA is a France-based company engaged in the medical sector. The Company develops invasive medical instruments used in preventing and treating vertebral fractures. The Company markets its flagship product, SpineJack, in Germany, the United Kingdom, Austria and Ireland under a agreement with Stryker Corp, in France via its... (more)

Overall

Beta: 0.20
Market Cap(Mil.): €75.95
Shares Outstanding(Mil.): 7.62
Dividend: --
Yield (%): --

Financials

  ALVXM.PA Industry Sector
P/E (TTM): -- 37.43 36.51
EPS (TTM): -0.69 -- --
ROI: -34.34 12.48 13.85
ROE: -34.80 14.80 14.77

BRIEF-Vexim H1 net loss narrows to 2.5 million euros

* H1 net loss EUR 2.5 million ($2.79 million)versus loss of EUR 3.6 million year ago

Sep 20 2016

BRIEF-Vexim signs an agreement with Creatori Health

* Vexim signs a distribution agreement with Creatori Health and expands its market to South Africa Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Sep 13 2016

BRIEF-Vexim registers SpineJack and Masterflow for the treatment of vertebral fractures in Australia

* Vexim announces the registration of its products SpineJack and Masterflow for the treatment of vertebral fractures in Australia Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Sep 06 2016

BRIEF-Vexim Q3 revenue up 37 pct at 4.6 mln euros

* Q2 revenue 4.6 million euros ($5.1 million) versus 3.4 million euros year ago

Jul 12 2016

BRIEF-Vexim Q1 revenue up at 4.0 million euros

* Q1 revenue 4.0 million euros versus 2.7 million euros year ago

Apr 14 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Reuters Investment Profile
$20.00
Provider : Wright Reports
$75.00
Provider : GlobalData
$300.00
Provider : Sadif Analytics Prime
$10.00
Provider : Sadif Analytics Prime
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.